National Research Council Canada

nrc-cnrc.gc.ca

The National Research Council of Canada (NRC) is the Government of Canada's largest research and technology organization. Working with our partners, we're delivering a national platform for innovation. We conduct research, support small and medium-sized companies to help them scale up and compete and we connect Canadian innovators to leading R&D capabilities. We also enable cross-sector partnership and collaboration here at home.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

INDUSTRIAL IMPACT

INHIBRX RECEIVES FDA ORPHAN-DRUG DESIGNATION FOR INBRX-101 FOR THE TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY

Inhibrx, Inc. | March 04, 2022

news image

Inhibrx, Inc. a biotechnology company with four clinical programs in development and a strong emerging pipeline, announced that the U.S. Food and Drug Administration, or FDA, has granted orphan-drug designation for INBRX-101 for the treatment of alpha-1 antitrypsin deficiency, or AATD. "We believe this designation from the FDA acknowledges the significant unmet need for novel therapeutic options in a patient community where the standard of care has not s...

Read More

GENETIC TESTING MARKET TO SET NEW GROWTH STORY: TRANSGENOMIC, GE HEALTHCARE, 23 & ME

EIN News | April 16, 2020

news image

Advance Market Analytics released the research report of Global Genetic Testing Market, offers a detailed overview of the factors influencing the global business scope. Global Genetic Testing Market research report shows the latest market insights with upcoming trends and breakdown of the products and services.The report provides key statistics on the market status, size, share, growth factors of the Global Genetic Testing. This Report covers the emerging player’s data, including: competit...

Read More

HOW DOES AVID BIOSERVICES INC (CDMO) STOCK COMPARE TO OTHERS IN BIOTECHNOLOGY?

InvestorsObserver | April 22, 2020

news image

Avid Bioservices Inc (CDMO) is around the top of the Biotechnology industry according to InvestorsObserver. CDMO received an overall rating of 68, which means that it scores higher than 68 percent of all stocks. Avid Bioservices Inc also achieved a score of 76 in the Biotechnology industry, putting it above 76 percent of Biotechnology stocks. Biotechnology is ranked 7 out of the 148 industries. What do These Ratings Mean? Finding the best stocks can be tricky. It isn’t easy to compare comp...

Read More

MEDTECH

NOVOZYMES AND SAIPEM ENTER COLLABORATION AGREEMENT TO CREATE A MORE SUSTAINABLE CO2 CAPTURE

Novozymes | December 13, 2021

news image

Novozymes, the world leader in biological solutions, and Saipem, an advanced technological and engineering platform for safe and sustainable complex infrastructure and plants, have signed a collaboration agreement for the development of innovative solutions for enzymatic carbon capture. As part of the agreement, Saipem - which owns an enzyme-based CO2 capture technology - will be responsible for providing process, mechanical and equipment design, while Novozymes will provide enzym...

Read More
news image

INDUSTRIAL IMPACT

INHIBRX RECEIVES FDA ORPHAN-DRUG DESIGNATION FOR INBRX-101 FOR THE TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY

Inhibrx, Inc. | March 04, 2022

Inhibrx, Inc. a biotechnology company with four clinical programs in development and a strong emerging pipeline, announced that the U.S. Food and Drug Administration, or FDA, has granted orphan-drug designation for INBRX-101 for the treatment of alpha-1 antitrypsin deficiency, or AATD. "We believe this designation from the FDA acknowledges the significant unmet need for novel therapeutic options in a patient community where the standard of care has not s...

Read More
news image

GENETIC TESTING MARKET TO SET NEW GROWTH STORY: TRANSGENOMIC, GE HEALTHCARE, 23 & ME

EIN News | April 16, 2020

Advance Market Analytics released the research report of Global Genetic Testing Market, offers a detailed overview of the factors influencing the global business scope. Global Genetic Testing Market research report shows the latest market insights with upcoming trends and breakdown of the products and services.The report provides key statistics on the market status, size, share, growth factors of the Global Genetic Testing. This Report covers the emerging player’s data, including: competit...

Read More
news image

HOW DOES AVID BIOSERVICES INC (CDMO) STOCK COMPARE TO OTHERS IN BIOTECHNOLOGY?

InvestorsObserver | April 22, 2020

Avid Bioservices Inc (CDMO) is around the top of the Biotechnology industry according to InvestorsObserver. CDMO received an overall rating of 68, which means that it scores higher than 68 percent of all stocks. Avid Bioservices Inc also achieved a score of 76 in the Biotechnology industry, putting it above 76 percent of Biotechnology stocks. Biotechnology is ranked 7 out of the 148 industries. What do These Ratings Mean? Finding the best stocks can be tricky. It isn’t easy to compare comp...

Read More
news image

MEDTECH

NOVOZYMES AND SAIPEM ENTER COLLABORATION AGREEMENT TO CREATE A MORE SUSTAINABLE CO2 CAPTURE

Novozymes | December 13, 2021

Novozymes, the world leader in biological solutions, and Saipem, an advanced technological and engineering platform for safe and sustainable complex infrastructure and plants, have signed a collaboration agreement for the development of innovative solutions for enzymatic carbon capture. As part of the agreement, Saipem - which owns an enzyme-based CO2 capture technology - will be responsible for providing process, mechanical and equipment design, while Novozymes will provide enzym...

Read More